Wixela vs Breo
What to choose Wixela or Breo
Wixela is inhaler of type Control while Breo is of Rescue type. Wixela and Breo are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Breo is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substance of Breo is Vilanterol. The available dosages for Breo are 100/25, 200/25.
The current cost for Wixela is around $240 while average price for Breo is approximately $145, said Spencer Butler, a Scholar at the University of Pittsburgh at Johnstown and a Medical Assistant at a clinic that uses Wixela and Breo.
Wixela and Breo Comparison
| Wixela | Breo | |
|---|---|---|
| Type: | Control | Rescue |
| Manufacturer: | Viatris | GSK |
| Substance: | Fluticasone + Salmeterol | Vilanterol |
| Dosage: | 250/50 | 100/25, 200/25 |
| Avg Price: | $240 | $145 |